Irritable Bowel Syndrome (IBS) Treatment Market Forecast Report 2024: An Expected $7.60 Billion Industry in 2032

Treating Spastic Colitis with the Irritable Bowel Syndrome (IBS) Treatment Market

Irritable bowel syndrome (IBS), also referred to as spastic colon, irritable colon, and spastic colitis, is a common condition that affects the gastrointestinal tract. It’s characterized by uncomfortable or painful abdominal symptoms linked to altered bowel movements. The exact cause of IBS is unknown, though it’s been associated with things such as oversensitive gut nerves, very quick or slow passage of food through the gut, stress, and family history of IBS. As a lifelong problem, IBS can have a big impact on the individual’s everyday life and can be highly frustrating to live with.

“According to the research report, the global irritable bowel syndrome (IBS) treatment market was valued at USD 3.69 billion in 2023 and is expected to reach USD 7.60 billion by 2032, to grow at a CAGR of 8.4% during the forecast period.”

Request Our Free Sample Report for Irritable Bowel Syndrome (IBS) Treatment Market Insights and Emerging Trends @

Is There a Cure for Irritable Bowel Syndrome (IBS)?

The most common symptoms of IBS are abdominal pain, usually related to bowel movements and changes in bowel movements. To treat IBS, physicians will review the patient’s symptoms, their medical and family history and conduct a physical exam. In some cases, doctors may order specific tests to rule out other health conditions. IBS is usually treated by making dietary and lifestyle changes, such as avoiding gluten, eating more fiber, or following a specific diet. Besides, medicines, probiotics, and mental health therapies may be recommended to patients. The advent of numerous drug pipelines to treat IBS is anticipated to be a significant driver of the irritable bowel syndrome (IBS) treatment market growth.

See also  Green Food Supplements Market Size, Share, Emerging Trend, Global Demand, Key Players Review and Forecast to 2032

Competitive Landscape

This section of the report covers an in-depth examination of the competitive environment in the industry. It introduces industry vendors from the perspective of market share, concentration ratio, etc. Also, it offers a thorough analysis of the Irritable Bowel Syndrome (IBS) Treatment Market key players to help readers gain an in-depth understanding of the competitive landscape in the industry. Furthermore, all the major strategic developments, such as mergers, acquisitions, and collaborations, are considered.

Top Key Players:

  • Astellas Pharma Inc
  • GlaxoSmithKline Plc
  • Abbott Laboratories
  • Takeda Pharmaceutical Company Ltd
  • Johnson & Johnson
  • Novartis AG
  • AstraZeneca plc
  • Sebela Pharmaceuticals Inc
  • Synthetic Biologics Inc
  • Bausch Health
  • Synergy Pharmaceuticals Inc.

Access Key Players with their key Offerings as you Download your PDF Sample Copy @

Growth Factors

  • Market dynamics: All the key factors and major developments anticipated to boost the growth of the market are covered in the study.
  • Technological evolution: The report offers a thorough understanding of the emerging technologies that can influence the Irritable Bowel Syndrome (IBS) Treatment Market demand.
  • Innovation pathways: The study covers where innovations can take the market in the mid to long term.

Segmental Overview

The Irritable Bowel Syndrome (IBS) Treatment Market is primarily segmented by type, application, end-use, and region. A proper splitting of the industry into different groups allows businesses to understand market preferences and trends better. Also, it helps industry players to develop new products/services that meet the needs of diverse consumer groups in the industry. Besides, a thorough overview of all the major sub-segments is included in the report.

See also  Hollow Concrete Blocks Market Size is projected to Reach USD 402.36 Billion by 2032, Growing at a CAGR of 5.0%: Polaris Market Research

Request for Customization on This Report as Per Your Requirements @

Polaris Market Research has segmented the Irritable Bowel Syndrome (IBS) Treatment market report based on type, application, shape, distribution channel, and region:

Irritable Bowel Syndrome (IBS) Treatment, Medical Condition Outlook (Revenue – USD Billion, 2019 – 2032)

  • IBS – Diarrhea
  • IBS – Constipation
  • IBS – Mixed

Irritable Bowel Syndrome (IBS) Treatment, Drug Type Outlook (Revenue – USD Billion, 2019 – 2032)

  • Ramosetron Hydrochloride
  • Linaclotide
  • Rifaximin
  • Eluxadoline
  • Lubiprostone
  • Others

Irritable Bowel Syndrome (IBS) Treatment, Distribution Channel Outlook (Revenue – USD Billion, 2019 – 2032)

  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies

Regional Analysis

This section of the study sheds light on the geographic analysis of the Irritable Bowel Syndrome (IBS) Treatment Market. It covers various aspects such as market share, gross margin, and growth rate to offer a thorough analysis of every region. Besides, it covers the regions with the highest growth potential and examines all the top sub-regions in the industry.

The Geographical Analysis Covers Following Key Regions:

  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and the Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and the rest of South America)
  • The Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, South Africa, and the Rest of the Middle East and Africa)

Inquire or Share Your Questions If Any Before Purchasing This Report @

Key Features of the Report

  • The report offers an in-depth Irritable Bowel Syndrome (IBS) Treatment Market analysis to support informed decision-making.
  • It strengthens your business strategies and adds substance to your presentations with reliable research.
  • Offers crucial information on key market players, giving you a strategic edge.
  • Accurately assesses the changing competitive dynamics, keeping readers at the forefront of key developments and trends.
  • It provides a deep dive into the market with a meticulous breakdown of various market niches.
See also  Hermetic Packaging Market Share to Reach $7.75 Billion Globally, by 2032 at 4.8% CAGR: Polaris Market Research

The Report Answers Questions Such As

  • What is the current market size and forecast value?
  • What are the key opportunities and challenges in the industry?
  • How emerging trends and technologies are shaping the future of the Irritable Bowel Syndrome (IBS) Treatment Market?
  • What is the estimated demand for different types of products/services in the market?
  • Who are the major players operating in the industry?
  • What are the projections of the industry considering capacity, production, and production value?

Unlock Instant Access | Acquire This Premium Research Report @

About Us:

Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

Contact Us:

Polaris Market Research
30 Wall Street, 8th Floor,
New York City, NY 10005,
United States
Phone:+1-929 297-9727